Invivyd, Inc.
IVVD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001832038
In the last 90 days, Invivyd, Inc. insiders filed 0 open-market purchases and 5 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $203.1M in total; Maverick Capital is the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Invivyd, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 75 | 2 | 76 | +3 |
| Shares | 59.3M | 15.6K | 60.7M | +1.41M (+2.4%) |
| Value | $269.7M | $71.0K | $198.1M | −$71.5M (−26.5%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Invivyd, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rubric Capital Management LP | 1,812,347 | $5.94M | 0.31% |
| Newtyn Management, LLC | 400,875 | $1.31M | 0.25% |
| HRT Financial LP | 238,170 | $781.0K | 0.01% |
| ArrowMark Colorado Holdings LLC | 227,660 | $747.0K | 0.01% |
| Woodline Partners LP | 198,962 | $653.0K | 0.01% |
| Millennium Management LLC | 95,499 | $313.0K | 0.00% |
| Alps Advisors Inc | 65,095 | $214.0K | 0.00% |
| Ergoteles LLC | 50,100 | $164.0K | 0.00% |
| Prelude Capital Management, LLC | 21,800 | $72.0K | 0.00% |
| Voya Investment Management LLC | 19,953 | $65.0K | 0.00% |
| SG Americas Securities, LLC | 18,080 | $59.0K | 0.00% |
| Invesco Ltd. | 16,001 | $52.0K | 0.00% |
| Clear Harbor Asset Management, LLC | 14,500 | $48.0K | 0.01% |
| Two Sigma Advisers, LP | 11,600 | $38.0K | 0.00% |
| Group One Trading, L.P. | 9,372 | $31.0K | 0.00% |
| Cannell Capital LLC | 3,357 | $11.0K | 0.00% |
| Glassman Wealth Services | 200 | $1.00K | 0.00% |
| Credit Suisse AG | 56 | $0 | 0.00% |
Sold out (15)
Institutions that held Invivyd, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Third Point LLCSuperinvestorThird Point | 987,114 | $4.50M |
| Franklin Resources Inc | 809,053 | $3.69M |
| Susquehanna International Group, LLP | 226,975 | $1.03M |
| Voloridge Investment Management, LLC | 66,807 | $305.0K |
| MetLife Investment Management | 38,979 | $177.7K |
| PDT Partners, LLC | 35,188 | $160.0K |
| State of Wisconsin Investment Board | 27,700 | $126.0K |
| Gsa Capital Partners LLP | 21,505 | $98.0K |
| Point72 Hong Kong Ltd | 12,026 | $55.0K |
| ProShare Advisors LLC | 11,037 | $51.0K |
| Cubist Systematic Strategies, LLC | 7,100 | $32.0K |
| Metropolitan Life Insurance Co | 4,567 | $20.8K |
| Dark Forest Capital Management LP | 2,927 | $13.0K |
| Quantbot Technologies LP | 700 | $3.00K |
| State of Wyoming | 743 | $3.00K |
Not filed for Q2 2022 yet (2)
Institutions that held Invivyd, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 10,581 | $48.0K |
| Amalgamated Financial Corp. | 5,042 | $23.0K |